Bausch Health Companies Inc.: Glaucoma trials

The registry lists 10 Glaucoma studies with Bausch Health Companies Inc. as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 2Phase 2 7Phase 3 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and IOP-Lowering Effects of WB007CompletedNCT04149899Phase 1/2Results posted
• Therapeutic Equivalence Study of Generic Brinzolamide vs AzoptCompletedNCT03896633Phase 1/2Results posted
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHTCompletedNCT01895972Phase 3Results posted
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749930Phase 3Results posted
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749904Phase 3Results posted
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01707381Phase 2Results posted
• Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01223378Phase 2Results posted
• A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.CompletedNCT00595101Phase 2Results posted
• Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for GlaucomaCompletedNCT00441883Phase 2Results posted
• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT07168902Phase 2